Clinical Trial of TQB2825 Injection Combined Immunochemotherapy in Subjects With Diffuse Large B Cell Lymphoma

Clinical trial NCT06829771 · RECRUITING

Trial details

NCT number: NCT06829771
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma

Start date: 2025-04-23
Primary completion: 2026-05-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.